Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption.

Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption.

Anti-glomerular basement membrane (GBM) antibody disease may lead to acute crescentic glomerulonephritis with poor renal prognosis. Current therapy favours plasma exchange (PE) for removal of pathogenic antibodies. Immunoadsorption (IAS) is superior to PE regarding efficiency of antibody-removal and...

Full description

Bibliographic Details
Main Authors: Peter Biesenbach, Renate Kain, Kurt Derfler, Thomas Perkmann, Afschin Soleiman, Alexandra Benharkou, Wilfred Druml, Andrew Rees, Marcus D Säemann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4117516?pdf=render

Internet

http://europepmc.org/articles/PMC4117516?pdf=render

Similar Items